Biomedical Engineering Reference
In-Depth Information
35. Sharp J, Hatch M, Nistor G, Keirstead H (2011) Derivation of oligodendrocyte progenitor
cells from human embryonic stem cells. Methods Mol Biol 767:399-409
36. Krencik R, Weick JP, Liu Y, Zhang ZJ, Zhang SC (2011) Specification of transplantable
astroglial subtypes from human pluripotent stem cells. Nat Biotechnol 29:528-534
37. Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441:1075-1079
38. Vunjak-Novakovic G, Scadden DT (2011) Biomimetic platforms for human stem cell
research. Cell Stem Cell 8:252-261
39. Gobaa S, Hoehnel S, Roccio M, Negro A, Kobel S, Lutolf MP (2011) Artificial niche
microarrays for probing single stem cell fate in high throughput. Nat Methods 8:949-955
40. Park KI, Teng YD, Snyder EY (2002) The injured brain interacts reciprocally with neural
stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20:1111-1117
41. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD,
Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S,
Lichtenbelt KD, Tartaglia M, Gelb BD, Lemischka IR (2010) Patient-specific induced
pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465:808-812
42. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN (2009)
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280
43. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM,
Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, Studer L (2009) Modelling
pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature
461:402-406
44. Liu GH, Barkho BZ, Ruiz S, Diep D, Qu J, Yang SL, Panopoulos AD, Suzuki K, Kurian L,
Walsh C, Thompson J, Boue S, Fung HL, Sancho-Martinez I, Zhang K, Yates J 3rd (2011)
Izpisua Belmonte, J.C.: Recapitulation of premature ageing with iPSCs from Hutchinson-
Gilford progeria syndrome. Nature 472:221-225
45. Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, Hallmayer J, Dolmetsch RE (2011)
Using
induced
pluripotent
stem
cells
to
investigate
cardiac
phenotypes
in
Timothy
syndrome. Nature 471:230-234
46. Hockemeyer D, Jaenisch R (2010) Gene targeting in human pluripotent cells. Cold Spring
Harb Symp Quant Biol 75:201-209
47. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y,
Miller JC, Zeitler B, Cherone JM, Meng X, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD,
Jaenisch R (2011) Genetic engineering of human pluripotent cells using TALE nucleases.
Nat Biotechnol 29:731-734
48. Soldner F, Laganière J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V,
Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov
FD, Rebar EJ, Gregory PD, Zhang HS, Jaenisch R (2011) Generation of isogenic pluripotent
stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146:
318-331
49. Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P, Kee P, Schule B,
Dolmetsch RE, Langston W, Palmer TD, Pera RR (2011) LRRK2 mutant iPSC-derived DA
neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8:267-280
50. Saha K, Jaenisch R (2009) Technical challenges in using human induced pluripotent stem
cells to model disease. Cell Stem Cell 5:584-595
51. Renfranz PJ, Cunningham MG, McKay RD (1991) Region-specific differentiation of the
hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain.
Cell 66:713-729
52. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL,
Wolfe JH, Kim SU, Snyder EY (1998) Engraftable human neural stem cells respond to
developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16:
1033-1039
53. Englund U, Bjorklund A, Wictorin K, Lindvall O, Kokaia M (2002) Grafted neural stem
cells develop into functional pyramidal neurons and integrate into host cortical circuitry.
Proc Natl Acad Sci USA 99:17089-17094
